GCA
EVH icon

Genesee Capital Advisors’s Evolent Health EVH Stock Holding History

Genesee Capital Advisors’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-36,394
Closed -$1.19M – 134
2024
Q1 		$1.19M Sell
36,394
-1,996
-5% -$63.7K 0.65% 40
2023
Q4 		$1.27M Buy
38,390
+825
+2% +$23.3K 0.78% 35
2023
Q3 		$1.02M Sell
37,565
-3,031
-7% -$84.3K 0.74% 37
2023
Q2 		$1.23M Sell
40,596
-34,280
-46% -$1.11M 0.84% 33
2023
Q1 		$2.43M Sell
74,876
-1,360
-2% -$43K 1.73% 14
2022
Q4 		$2.14M Sell
76,236
-5,934
-7% -$170K 1.6% 14
2022
Q3 		$2.95M Sell
82,170
-1,461
-2% -$51.5K 2.25% 11
2022
Q2 		$2.57M Sell
83,631
-13,550
-14% -$395K 1.79% 13
2022
Q1 		$3.14M Sell
97,181
-2,362
-2% -$61.8K 1.64% 14
2021
Q4 		$2.75M Sell
99,543
-5,960
-6% -$171K 1.31% 20
2021
Q3 		$3.27M Buy
+105,503
New +$2.53M 1.61% 13

Other funds holding EVH

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Genesee Capital Advisors's EVH Position: Q2 2024 in Review

Genesee Capital Advisors sold out of Evolent Health (EVH) in Q2 2024, closing a stake of 36,394 shares — an estimated $1.19M sold.

Genesee Capital Advisors first reported a position in EVH in Q3 2021 and held it in 11 quarters. The position peaked at $3.27M in Q3 2021. 243 funds tracked by Wall St. Rank hold EVH as of Q2 2024.

  • Genesee Capital Advisors reported no remaining Evolent Health position as of Q2 2024 after selling out during the quarter.
  • Genesee Capital Advisors sold 36,394 Evolent Health shares in Q2 2024, an estimated $1.19M.
  • Genesee Capital Advisors first reported a position in Evolent Health in Q3 2021 and held it in 11 quarters.
  • Genesee Capital Advisors's Evolent Health position peaked at $3.27M in Q3 2021.
  • 243 funds tracked by Wall St. Rank held Evolent Health as of Q2 2024.

Based on Genesee Capital Advisors's 13F filing for Q2 2024, filed 18 Jul 2024.